Replay | Ausbiz Capital Investor Connect Presentation

Orthocell CEO and Managing Director Paul Anderson presented at the Ausbiz Capital Investor Connect Biotech & Pharmaceuticals Special, where he provided an update on the Company’s commercial progress and global expansion strategy. The presentation focused on the US rollout of Remplir™, where market access activities continue to progress as planned, supported by growing surgeon adoption and increasing sales momentum.